Cargando…

Sonodynamic therapy suppresses matrix collagen degradation in vulnerable atherosclerotic plaque by modulating caspase 3 - PEDF/HIF-1α - MMP-2/MMP-9 signaling in macrophages

BACKGROUND: The rupture of vulnerable atherosclerotic plaque is the main cause of acute ischemic vascular events, and is characterized by pathological degradation of matrix collagen in the fibrous cap. In a previous study, we reported that 5-aminolevulinic acid-mediated sonodynamic therapy suppresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yanfeng, Sheng, Siqi, Gao, Weiwei, Yao, Jianting, Tian, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794047/ https://www.ncbi.nlm.nih.gov/pubmed/36574366 http://dx.doi.org/10.1371/journal.pone.0279191

Ejemplares similares

Relationship of MMP-14 and TIMP-3 Expression with Macrophage Activation and Human Atherosclerotic Plaque Vulnerability
por: Johnson, Jason L., et al.
Publicado: (2014)

Sonodynamic Therapy of Atherosclerotic Plaques: Breaking the Cycle
por: Ziegler, Tilman, et al.
Publicado: (2020)

Sonodynamic Therapy Suppresses Neovascularization in Atherosclerotic Plaques via Macrophage Apoptosis-Induced Endothelial Cell Apoptosis
por: Yao, Jianting, et al.
Publicado: (2019)

Sonodynamic therapy reduces iron retention of hemorrhagic plaque
por: Li, Bicheng, et al.
Publicado: (2020)

Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction
por: Chen, Lilin, et al.
Publicado: (2018)

MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells
por: Rao, Velidi H., et al.
Publicado: (2014)

Correlations of MMP-1, MMP-3, and MMP-12 with the degree of atherosclerosis, plaque stability and cardiovascular and cerebrovascular events
por: Hu, Wei, et al.
Publicado: (2018)

Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
por: Orozco-Páez, Jennifer, et al.
Publicado: (2021)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia
por: Laskowska, Marzena
Publicado: (2017)

The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes
por: Luchian, Ionut, et al.
Publicado: (2022)

Discoidin Domain-Containing Receptor 2 Is Present in Human Atherosclerotic Plaques and Involved in the Expression and Activity of MMP-2
por: Yu, Qi, et al.
Publicado: (2021)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Role of Matrix Metalloproteinase (MMP) 2 and MMP-9 in Soft Tissue Sarcoma
por: Yang, Hyun Kee, et al.
Publicado: (2014)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

The effect of intravascular interventional embolization and craniotomy on MMP-2, MMP-9 and caspase3 in serum of intracranial aneurysm patients
por: Zou, Liang, et al.
Publicado: (2018)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

The Therapeutic Effects of a PEDF-Derived Short Peptide on Murine Experimental Dry Eye Involves Suppression of MMP-9 and Inflammation
por: Ho, Tsung-Chuan, et al.
Publicado: (2022)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Inhibition of MMP1, MMP2 and MMP8 by mepacrine
por: Pollaschek, C, et al.
Publicado: (2003)

Effect of Kaempferol on the Biological Behavior of Human Colon Cancer via Regulating MMP1, MMP2, and MMP9
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Association of MMP3, MMP14, and MMP25 gene polymorphisms with cerebral stroke risk: a case-control study
por: Yin, Yanling, et al.
Publicado: (2023)

Matrix Metalloproteinases MMP-2 and MMP-9 Occupy a New Role in Severe Preeclampsia
por: Timokhina, Elena, et al.
Publicado: (2020)

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

An MMP-degradable and conductive hydrogel to stabilize HIF-1α for recovering cardiac functions
por: Wei, Xiaojuan, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)

MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
por: Tolboom, TCA, et al.
Publicado: (2001)

Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
por: Ruddy, Jean Marie, et al.
Publicado: (2016)

Metformin Directly Binds to MMP-9 to Improve Plaque Stability
por: Chen, Xianda, et al.
Publicado: (2023)

Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo
por: Ågren, Magnus S., et al.
Publicado: (2015)

Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_paksgg6fjtjdfr83n3lvdh3cvm